As evidence mounts that the current Zika epidemic in Latin America may have peaked, the public health effort is now shifting to developing a long-term
The Task Force is supporting the development of two new polio antiviral therapies to treat immune-deficient people who excrete poliovirus after receiving oral polio vaccine
The Task Force is facilitating clinical trials for a promising new treatment to combat a disfiguring disease known as elephantiasis, which can result from infection
GSK Chief Executive Officer (CEO) Sir Andrew Witty is one of the pharmaceutical industry’s most passionate advocates for increasing access to essential medicines and vaccines
Sign up for our monthly newsletter to get updates about our work.
If you live in the European Union, please sign up here.
